戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 erived ataxin-7, which contains a pathogenic polyglutamine expansion.
2 bberant protein interactions mediated by the polyglutamine expansion.
3  C terminal to amino acid 221 to include the polyglutamine expansion.
4 enerative disorder caused by ataxin-3 with a polyglutamine expansion.
5  Huntingtin (Htt), that contains an abnormal polyglutamine expansion.
6 uclear factor or process is disrupted by the polyglutamine expansion.
7 dels of tauopathy, amyloid beta-peptide, and polyglutamine expansion.
8 ease (HD) is expression of huntingtin with a polyglutamine expansion.
9 e epitope of human huntingtin is enhanced by polyglutamine expansion.
10 f many neurodegenerative disorders caused by polyglutamine expansion.
11 ited neurodegenerative disorders result from polyglutamine expansions.
12 1 hereditary neurological diseases involving polyglutamine expansions.
13  the huntingtin protein (mHTT) with aberrant polyglutamine expansions.
14                                     Although polyglutamine expansion accelerates protein aggregation,
15                    Our findings suggest that polyglutamine expansion alters androgen receptor functio
16  N-terminus of mutant huntingtin (htt) has a polyglutamine expansion and forms neuronal aggregates in
17 cytoplasmic inclusions, which increased with polyglutamine expansion and with time after transfection
18 ne, we demonstrate that, while determined by polyglutamine expansion, ataxin-1 aggregation is noticea
19                               Concomitantly, polyglutamine expansion attenuates the formation and fun
20 itors inhibit oxidative death independent of polyglutamine expansions by activating an Sp1-dependent
21          In at least nine inherited diseases polyglutamine expansions cause neurodegeneration associa
22                                          The polyglutamine expansion causes huntingtin to interact ab
23                                              Polyglutamine expansion causes Huntington disease (HD) a
24                       In Huntington disease, polyglutamine expansion causes N-terminal huntingtin (Ht
25              While the mechanism(s) by which polyglutamine expansion causes neurodegeneration in each
26                             To elucidate how polyglutamine expansion causes neuronal dysfunction, we
27                  In Huntington disease (HD), polyglutamine expansion causes the disease protein hunti
28 s are decreased in disease suggests that the polyglutamine expansion contributes to disease by both a
29                                We found that polyglutamine expansion decreased ATXN7 occupancy, which
30 onsible for Spinocerebellar ataxia type 3, a polyglutamine expansion disease, represents one of such
31 se data support a CBP-sequestration model of polyglutamine expansion disease.
32 Spinocerebellar ataxia type 1 is one of nine polyglutamine expansion diseases and is characterized by
33                       This disease and other polyglutamine expansion diseases are characterized by la
34 n in HD, and may have implications for other polyglutamine expansion diseases in which mutant protein
35 tly proposed mechanisms of neuronal death in polyglutamine expansion diseases include activation of c
36 o its role in the molecular pathology of the polyglutamine expansion diseases, mutations of the prote
37                                 The dominant polyglutamine expansion diseases, which include spinocer
38 nesis and selective neuronal degeneration of polyglutamine expansion diseases.
39 regates that have been identified in the CAG/polyglutamine expansion diseases.
40 elationship between this disease and the CAG/polyglutamine expansion diseases.
41                            HD is one of nine polyglutamine expansion diseases.
42 nce AR SUMOylation may be of clinical use in polyglutamine expansion diseases.
43 e therapy for Huntington's disease and other polyglutamine-expansion diseases.
44 e those seen in models of Kennedy disease, a polyglutamine expansion disorder caused by a CAG repeat
45 se Spinocerebellar ataxia type 1 (SCA1) is a polyglutamine expansion disorder characterized by the de
46  disease (HD) is the most commonly inherited polyglutamine expansion disorder, but how mutant Hunting
47 ntington disease patients (and perhaps other polyglutamine expansion disorders).
48 nd neurodegenerative diseases, including the polyglutamine expansion disorders, because of its abilit
49 is increasingly implicated in the biology of polyglutamine expansion disorders, Parkinson's disease a
50 therapeutic target for treating HD and other polyglutamine expansion disorders.
51                           Here, we find that polyglutamine expansions disrupted the global balance of
52 Data from the present study demonstrate that polyglutamine expansion does not dramatically impair pro
53 sight, down to the molecular level, into how polyglutamine expansion drives aggregation and explains
54 nd genetic studies provide evidence that the polyglutamine expansion enhances interactions that are n
55 ing and immunoprecipitation assays show that polyglutamine expansion enhances the interaction of N-te
56       Huntington's disease (HD) is caused by polyglutamine expansion (exp) in huntingtin (Htt).
57       Huntington's disease (HD) is caused by polyglutamine expansion (exp) in huntingtin.
58 c features, we have examined the behavior of polyglutamine expansions expressed in Caenorhabditis ele
59 hology of expanded CAG repeat disorders with polyglutamine expansions expressed within the affected p
60                                      Whereas polyglutamine expansion-expressing animals with WT therm
61                    The clinical threshold of polyglutamine expansion for HD is near 37 repeats, but t
62                                          CAG/polyglutamine expansion has been shown to form the molec
63  intracellular consequences of expression of polyglutamine expansion have been the object of intensiv
64 ssociated protein huntingtin with a 103 copy-polyglutamine expansion (HTT gene; htt-103Q).
65 misfolded huntingtin exon I containing a 103-polyglutamine expansion (Htt103QP) as a model substrate
66                 Our results demonstrate that polyglutamine expansion impairs the ability of huntingti
67                                              Polyglutamine expansion in androgen receptor (AR) is res
68 inant neurodegenerative disorder caused by a polyglutamine expansion in ataxin-3 (ATX3; MJD1) protein
69                                 For example, polyglutamine expansion in ataxin-3 allosterically trigg
70 SCA3, a neurodegenerative disorder caused by polyglutamine expansion in ataxin-3.
71                                              Polyglutamine expansion in ATXN1 favours the formation o
72                                              Polyglutamine expansion in certain proteins causes neuro
73 (HD), which is a movement disorder caused by polyglutamine expansion in Htt.
74 neurodegenerative disease caused by abnormal polyglutamine expansion in huntingtin (Exp-HTT) leading
75                                            A polyglutamine expansion in huntingtin (HTT) causes the s
76 rodegenerative disease caused by an abnormal polyglutamine expansion in huntingtin (Htt).
77                                 However, how polyglutamine expansion in huntingtin promotes glutamate
78  corepressor C-terminal binding protein, and polyglutamine expansion in huntingtin reduced this inter
79              Huntington disease is caused by polyglutamine expansion in huntingtin, a 350 kD protein
80 untington's disease (HD), which is caused by polyglutamine expansion in huntingtin.
81 used by a genetic mutation that results in a polyglutamine expansion in huntingtin.
82          Huntington's disease is caused by a polyglutamine expansion in huntingtin.
83 minant neurodegenerative disease caused by a polyglutamine expansion in huntingtin.
84                       The mechanism by which polyglutamine expansion in Huntington's disease (HD) res
85             Huntingtin, a protein altered by polyglutamine expansion in Huntington's disease (Httexp)
86 s, we and others have recently reported that polyglutamine expansion in purified or recombinantly exp
87 herited neurodegenerative diseases caused by polyglutamine expansion in the affected proteins.
88 eurodegenerative disorder caused by abnormal polyglutamine expansion in the amino-terminal end of the
89                                              Polyglutamine expansion in the androgen receptor (AR) ca
90 t in the huntingtin (Htt) protein; a similar polyglutamine expansion in the androgen receptor (AR) ca
91  bulbar muscular atrophy) is caused by a CAG/polyglutamine expansion in the androgen receptor (AR) ge
92  progressive neuromuscular disease caused by polyglutamine expansion in the androgen receptor (AR) pr
93 y progressive motor neuron disease caused by polyglutamine expansion in the androgen receptor (AR).
94  is a neurodegenerative disorder caused by a polyglutamine expansion in the androgen receptor (AR).
95 rophy and Huntington's disease are caused by polyglutamine expansion in the androgen receptor and hun
96                                              Polyglutamine expansion in the androgen receptor causes
97                                              Polyglutamine expansion in the androgen receptor, causin
98  bulbar muscular atrophy (SBMA) is caused by polyglutamine expansion in the androgen receptor, which
99  fatal neurodegenerative disease caused by a polyglutamine expansion in the coding region of ATXN1.
100     Huntington's disease (HD) is caused by a polyglutamine expansion in the disease protein huntingti
101                                              Polyglutamine expansion in the exon 1 domain of huntingt
102 gene huntingtin (HTT) that is reflected by a polyglutamine expansion in the Htt protein.
103                     We conclude that a small polyglutamine expansion in the human alpha 1A calcium ch
104                                          The polyglutamine expansion in the huntingtin (htt) protein
105 lmark of HD is neurodegeneration caused by a polyglutamine expansion in the huntingtin (htt) protein
106 a neurodegenerative disorder associated with polyglutamine expansion in the huntingtin (htt) protein.
107     Huntington's disease (HD) is caused by a polyglutamine expansion in the Huntingtin (Htt) protein.
108 neurodegenerative disease caused by abnormal polyglutamine expansion in the huntingtin protein (Htt).
109 nant neurodegenerative disorder, caused by a polyglutamine expansion in the huntingtin protein (htt).
110                                              Polyglutamine expansion in the huntingtin protein is the
111 tive disorder caused by an aggregation-prone polyglutamine expansion in the huntingtin protein.
112 erited neurodegenerative disease caused by a polyglutamine expansion in the huntington protein (htt).
113                                              Polyglutamine expansion in the N terminus of huntingtin
114         Huntington disease (HD) is caused by polyglutamine expansion in the N terminus of huntingtin
115 erited neurodegenerative condition caused by polyglutamine expansion in the N terminus of the hunting
116  The Huntington's disease (HD) mutation is a polyglutamine expansion in the N-terminal region of hunt
117 se is neurodegenerative disorder caused by a polyglutamine expansion in the N-terminal region of the
118 th Huntington disease (HD) is triggered by a polyglutamine expansion in the N-terminal region of the
119  ataxia type 1 (SCA1), a disease caused by a polyglutamine expansion in the protein ATAXIN1 (ATXN1).
120 erited neurodegenerative disease caused by a polyglutamine expansion in the protein huntingtin (Htt).
121 odegenerative disorder caused by an abnormal polyglutamine expansion in the protein Huntingtin (Htt).
122  inherited neurological disorder caused by a polyglutamine expansion in the protein huntingtin and is
123 se, a neurodegenerative disorder caused by a polyglutamine expansion in the protein huntingtin.
124  (SCA17), a neurological disease caused by a polyglutamine expansion in the TATA-binding protein (TBP
125 inherited neurodegenerative diseases share a polyglutamine expansion in their respective disease prot
126                                              Polyglutamine expansions in huntingtin, which causes Hun
127 se (HD) is a neurological disorder caused by polyglutamine expansions in mutated Huntingtin (mHtt) pr
128 ominant neurodegenerative disorder caused by polyglutamine expansions in the amino-terminal region of
129 cts males, results from a CAG triplet repeat/polyglutamine expansions in the androgen receptor (AR) g
130  in yeast and flies, and intermediate-length polyglutamine expansions in the ataxin-2 gene increase r
131                              HD is caused by polyglutamine expansions in the huntingtin (htt) protein
132  an indirect and poorly understood manner by polyglutamine expansions in the huntingtin (HTT) protein
133                 SCA2 results from a poly(Q) (polyglutamine) expansion in the cytosolic protein ataxin
134 neurodegenerative disease linked to a polyQ (polyglutamine) expansion in the huntingtin protein.
135  a fatal neurodegenerative disease caused by polyglutamine-expansion in huntingtin (HTT).
136 urodegenerative diseases are caused by a CAG/polyglutamine expansion, including spinal and bulbar mus
137                      Here, we establish that polyglutamine expansion increases the molecular mobility
138 gain further insights into the mechanisms of polyglutamine expansion-induced cell death, the Affymetr
139   Knowledge regarding the pathophysiology of polyglutamine-expansion-induced protein dysfunction is a
140 ediates its binding to huntingtin, and (iii) polyglutamine expansion interferes with the ability of h
141  huntingtin interacts with MLK2, whereas the polyglutamine expansion interferes with this interaction
142                                              Polyglutamine expansion is a hallmark of nine neurodegen
143 erturbation in a target protein induced by a polyglutamine expansion is also discussed.
144                                              Polyglutamine expansion is central for determining solub
145                                              Polyglutamine expansion is the cause of several neurodeg
146 nerative diseases, including those caused by polyglutamine expansion, is the formation of ubiquitin (
147 t is dependent on mutant huntingtin dose and polyglutamine expansion; many neurons die without formin
148 y (SBMA) is a motor neuron disease caused by polyglutamine expansion mutation in the androgen recepto
149     Huntington's disease (HD) is caused by a polyglutamine expansion mutation in the huntingtin prote
150 ssive neurodegenerative disorder caused by a polyglutamine expansion near the N-terminus of huntingti
151 ynamics and is a candidate disease sensor in polyglutamine expansion neurodegeneration.
152 , has been implicated in the pathogenesis of polyglutamine expansion neurodegenerative disease.
153 ction of ataxin-2 and the mechanism by which polyglutamine expansion of ataxin-2 causes neurodegenera
154 ction of ataxin-2 and the mechanism by which polyglutamine expansion of ataxin-2 causes neurodegenera
155 neurodegenerative disorder that results from polyglutamine expansion of the ataxin-7 (ATXN7) protein.
156 protein constructs to examine the effects of polyglutamine expansion on protein aggregation, proteaso
157  growth properties of mutant huntingtin with polyglutamine expansions or mutant SOD1 (G85R/G93A) to e
158                     Our results suggest that polyglutamine expansions perturb transcription of CREB/C
159 n, is affected by the mutant huntingtin with polyglutamine expansion (polyQ-htt).
160   Tat-beclin 1 decreases the accumulation of polyglutamine expansion protein aggregates and the repli
161  heat-shock proteins also delay the onset of polyglutamine-expansion protein aggregation, suggesting
162          Here we show, in animals expressing polyglutamine expansion proteins and mutant SOD-1(G93A)
163 the accumulation of SCA8 polyalanine and DM1 polyglutamine expansion proteins in previously establish
164 erminal mutant Huntingtin fragment or simple polyglutamine expansion proteins.
165 n expression of the highly aggregation-prone polyglutamine-expansion proteins and Abeta-peptide.
166 or a floxed exon 1 containing the pathogenic polyglutamine expansion (Q97).
167                                          How polyglutamine expansions render the resulting proteins t
168                               In addition to polyglutamine expansion, requirements for development of
169 ted with decreased clearance of protein with polyglutamine expansion, the accumulation of p62 in neur
170 l-length HD gene expression and differential polyglutamine expansion with possible pathophysiological
171                                              Polyglutamine expansion within the androgen receptor (AR
172                                              Polyglutamine expansion within the exon1 of huntingtin l
173 's disease (HD) is caused in large part by a polyglutamine expansion within the huntingtin (Htt) prot
174     Huntington's disease (HD) is caused by a polyglutamine expansion within the huntingtin (Htt) prot
175  is a neurodegenerative disorder caused by a polyglutamine expansion within the huntingtin protein.
176 untington's disease is caused by an abnormal polyglutamine expansion within the protein huntingtin an
177       Our results raise the possibility that polyglutamine expansions within ataxin-2 cause neurodege
178                                              Polyglutamine expansions within different proteins are a

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top